Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization

Nonrespiratory predictor of mechanical ventilation dependency in intensive care unit patients

OBJECTIVE

To determine the role of serum albumin concentration as a predictor of mechanical ventilation dependency.

DESIGN

Prospective, observation trial.

SETTING

Multidisciplinary intensive care unit (ICU) in a university hospital.

PATIENTS

One hundred forty-five consecutive patients who required mechanical ventilation for > 72 hrs.

INTERVENTIONS

Patients were classified into five different groups based on the cause of respiratory failure. The following parameters were recorded daily: serum albumin concentration; Acute Physiology and Chronic Health Evaluation II (APACHE II) score; and fluid balance. Using multiple regression, multiple logistic regression analysis, and the Anderson-Gill proportional hazards model, we determined the metabolic factors that could help predict weaning success.

MEASUREMENTS AND MAIN RESULTS

The mean length of ICU stay was 12.3 +/- 1.0 days. The duration of mechanical ventilation dependency was 10.5 +/- 1.0 days. The initial mean serum albumin concentration was 25.2 +/- 0.6 g/L. The APACHE II score on the first day of ICU stay was 19.1 +/- 0.6. Although albumin concentration was significantly lower and the APACHE II score was significantly higher in ICU nonsurvivors than in ICU survivors, albumin concentration on ICU admission was not a predictor of the length of time spent receiving mechanical ventilation. The profile of albumin concentration changes was different between weaned and mechanical ventilation-dependent patients. At the time of weaning patients from the ventilator, the median albumin concentration was higher than in those patients who continued to be supported by mechanical ventilation. This effect of albumin could not be attributed to patient fluid balance or to the severity of illness since each factor had an independent influence in predicting weaning, using the Anderson-Gill proportional hazards models.

CONCLUSIONS

Initial serum albumin concentration did not necessarily predict weaning success. However, when serum albumin concentration was assessed on a daily basis, its trend was important in determining the relative chance of being successfully weaned from the ventilator. This finding suggests that albumin may be an index of the metabolic status of the patient, which could be important in determining the weanability of the patients who are mechanically ventilated for prolonged periods of time.

[Role of albumin in pulmonary edema and septic shock, plasma volume expansion excluded]

Patients with septic shock deserve a global approach. Intravascular volume loading is part of the treatment. However several questions remain open: what are the respective contributions of volume expansion and vaso-active drugs in the restoration of blood pressure and increase of cardiac output, which volumes and type of solutions should be used, which pulmonary capillary wedge pressure should be targetted, and which evaluation criteria are the most appropriate? Few experimental and clinical studies provide evidence of a superiority of colloids over crystalloids, although none of them has documented a reduction of mortality, length of stay in ICU or duration of mechanical ventilation. There are no data support-ing a superiority of albumin over artificial colloids, which are also much cheaper. Moreover, hydroxyethylstarch could have promising properties in case of increased capillary permeability. In summary and in agreement with the North American consensus conference, albumin should not be recommended for the treatment of septic shock, whether associated with non cardiogenic pulmonary oedema or not.

Pulmonary complications in inhalation injuries with associated cutaneous burn

This retrospective study of 100 consecutive patients with inhalation injury documents that adult respiratory distress syndrome (ARDS) and pneumonia are common complications. Pulmonary complications cause or directly contribute to death in 77% of patients with combined inhalation and cutaneous burn injury. Additionally, the high fluid requirements of these patients worsens their pulmonary injury and is associated with adverse outcome. Independent factors predictive of death include ARDS and expected fluid requirements as well as age and percentage of total body surface area burned. An abnormal chest roentgenogram in the first 48 hours after injury is also associated with death. The development of ARDS is predicted by the actual volume of fluid resuscitation, despite normal pulmonary wedge pressure or normal central venous pressure reflecting increased microvascular permeability. These findings indicate a need for reevaluation of fluid resuscitation of patients with inhalation injury.

Acute respiratory distress syndrome

OBJECTIVE

To review the pathophysiology, epidemiology, and therapy of patients with acute respiratory distress syndrome (ARDS).

DATA SOURCES

Articles pertaining to the pathophysiology, epidemiology, and supportive therapy of ARDS were chosen from a computerized literature search. Recent review articles addressing the specifics of treatment in an intensive care unit are cited rather than restating these specific aspects.

DATA EXTRACTION

Primary literature was chosen in reference to the pathophysiology, epidemiology, and supportive therapy of ARDS. Both human and animal studies were included. Review articles were cited regarding areas of ARDS supportive therapy rather than citing the primary literature.

STUDY SELECTION

Only peer-reviewed primary literature sources were chosen to describe the specifics of pathophysiology and epidemiology. When human data were unavailable, animal studies were cited. Recent review articles were cited for specifics on supportive therapy.

DATA SYNTHESIS

Consensus regarding the definition of ARDS and the difficulties of performing large controlled trials in patients with ARDS has made development of new modalities problematic. Understanding the underlying pathophysiology and risk factors for mortality are key to supportive therapy. Although many pharmacologic agents are being tested in patients with ARDS, attention to the aspects of supportive therapy is the only method to decrease mortality.

CONCLUSION

The mortality of ARDS continues to be 70%. Pharmacists can play an active role in the supportive therapy of patients with ARDS, which is currently the only way to impact mortality.

Prevention and therapy of the adult respiratory distress syndrome

The complex pathophysiology of adult respiratory distress syndrome (ARDS) makes preventive and therapeutic concepts difficult. Ample experimental evidence indicates that ARDS can be prevented by blocking systemic inflammatory agents. Clinically, only heparin, for inhibition of coagulation phenomena, is presently used among this array of approaches. Corticosteroids have not proven to be beneficial in ARDS. Alternative antiinflammatory agents are being proposed and are under current clinical investigation (e.g. indomethacin, acetylcysteine, alpha 1-proteinase inhibitor, antitumor necrosis factor, interleukin 1 receptor antagonist, platelet-activating factor antagonists). Symptomatic therapeutic strategies in early ARDS include selective pulmonary vasodilation (preferably by inhaled vasorelaxant agents) and optimal fluid balance. Transbronchial surfactant application, presently tested in pilot studies, may be available for ARDS patients in the near future and may have acute beneficial effects on gas exchange, pulmonary mechanics, and lung hemodynamics; its impact on survival cannot be predicted at the present time. Strong efforts should be taken to reduce secondary nosocomial pneumonia in ARDS patients and thus avoid the vicious circle of pneumonia, sepsis from lung infection, and perpetuation of multiple organ dysfunction syndrome. Optimal respirator therapy should be directed to ameliorate gas-exchange conditions acutely but at the same time should aim at minimizing potentially aggravating side effects of artificial ventilation (barotrauma, O2 toxicity). Several new techniques of mechanical ventilation and the concept of permissive hypercapnia address these aspects. Approaches with extracorporeal CO2 removal and oxygenation are being used in specialized centers.

The acute respiratory distress syndrome

ARDS is a complex response of the lung to direct (inhalational) and indirect (hematogenous) insults. It is easy to be pessimistic about the benefit of the approaches we have described, but there is evidence that overall survival has improved in recent years. To maintain this progress, new therapies for ARDS must be rigorously evaluated, and their routine use should be recommended only after careful scrutiny of the evidence. Such a course will eliminate the unnecessary risks and costs often associated with unproved therapies.

Clinical lessons from an experimental model of ARDS

The oleic acid (OA) lung injury model is one of the most common laboratory methods for studying the acute respiratory distress syndrome (ARDS) in experimental animals. Many features of the model mimic the pathophysiology of ARDS in humans, despite obvious differences in pathogenesis. Thus, the OA lung injury model has been used extensively to study the consequence of lung injury and to evaluate potential new treatment strategies.

Value of elementary, combined, and modeled hemodynamic variables

PURPOSE

It has been well recognized that the usefulness of the clinical examination and simple hemodynamic variables in the critically ill is limited. Modelization for hemodynamic analysis may improve the diagnostic performance by a systematic and multivariate analysis. This requires a rigorous formalization that may otherwise expand the usefulness of hemodynamic data, both as predictors and as therapeutic targets. Our study was designed to test the value of a model for assessing the pathophysiology of circulatory disorders and for establishing the diagnosis.

METHODS

We tested all available variables using survival as the end point. A population of 223 patients (652 measurements) with compromised circulatory status was studied. We evaluated traditional variables: (1) morphological and physical data, (2) elementary right heart catheterization data, and (3) usually calculated variables, versus (4) new modeled variables. These new modeled variables were derived from a previously validated computer program for hemodynamic evaluation. They expressed differences between observed hemodynamic performance and estimated needs.

RESULTS

Among traditional variables, major prognostic factors were: (1) in all patients, lactate level elevation, physical signs of hypoperfusion, and a decreased systemic arterial pressure; (2) in septic patients, a high PaO2/SaO2 ratio; (3) in nonseptic patients, low left ventricle work indices. In all cases, modeled hemodynamic variables assessing performance-needs adequacy enhanced the prognostic value of hemodynamic monitoring.

CONCLUSIONS

Compared with traditional variables, modeled variables were found of greater interest to quantify pathophysiology of shock. These results enabled us to validate the initial step of the hemodynamic reasonning formalization and to develop "new" diagnostic criteria that more closely fit the interrelationship between pathophysiology, diagnosis, and prognosis.

Acute respiratory distress syndrome ("ARDS"): no more than a severe acute lung injury?

Images